Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Roth

Showing results (281-290 of 396) with videos related to

Pageof 40
Sort By:
Dalton Transactions (Cambridge, England : 2003)|May 18, 2011
Cu(I) catalysed cyclopropanation with enantiopure scorpionate type ligands derived from (+)-camphor or (-)-menthoneTom Godau, Sascha M Bleifuss, Astrid L Müller, et al.
Sleep Medicine|September 7, 2010
Efficacy and safety of doxepin 6 mg in a model of transient insomniaThomas Roth, H Heith Durrence, Philip Jochelson, et al.
Sleep Medicine|November 15, 2012
Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary studyTimothy Roehrs, Christina Diederichs, Mazy Gillis, et al.
Sleep Medicine|January 2, 2014
Validation of the Japanese version of the Ford Insomnia Response to Stress Test and the association of sleep reactivity with trait anxiety and insomniaShun Nakajima, Isa Okajima, Taeko Sasai, et al.
Journal of Clinical Medicine|August 29, 2018
The Association of Insomnia, Perceived Immune Functioning, and Irritable Bowel Syndrome ComplaintsStephanie Balikji, Marlou Mackus, Karel A Brookhuis, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trialMaurizio Fava, Gregory M Asnis, Ram K Shrivastava, et al.
Sleep|September 21, 2005
Sleep hygiene practices in a population-based sample of insomniacsCatherine D Jefferson, Christopher L Drake, Holly M Scofield, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 15, 2007
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depressionAndrew Krystal, Maurizio Fava, Robert Rubens, et al.
Journal of Sleep Research|August 4, 2009
Cortical locations of maximal spindle activity: magnetoencephalography (MEG) studyValentina Gumenyuk, Thomas Roth, John E Moran, et al.
Journal of Clinical Pharmacology|August 14, 2013
Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tabletsDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
Pageof 40

Showing results (281-290 of 396) with videos related to

Sort By:
Pageof 40
Dalton Transactions (Cambridge, England : 2003)|May 18, 2011
Cu(I) catalysed cyclopropanation with enantiopure scorpionate type ligands derived from (+)-camphor or (-)-menthoneTom Godau, Sascha M Bleifuss, Astrid L Müller, et al.
Sleep Medicine|September 7, 2010
Efficacy and safety of doxepin 6 mg in a model of transient insomniaThomas Roth, H Heith Durrence, Philip Jochelson, et al.
Sleep Medicine|November 15, 2012
Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary studyTimothy Roehrs, Christina Diederichs, Mazy Gillis, et al.
Sleep Medicine|January 2, 2014
Validation of the Japanese version of the Ford Insomnia Response to Stress Test and the association of sleep reactivity with trait anxiety and insomniaShun Nakajima, Isa Okajima, Taeko Sasai, et al.
Journal of Clinical Medicine|August 29, 2018
The Association of Insomnia, Perceived Immune Functioning, and Irritable Bowel Syndrome ComplaintsStephanie Balikji, Marlou Mackus, Karel A Brookhuis, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trialMaurizio Fava, Gregory M Asnis, Ram K Shrivastava, et al.
Sleep|September 21, 2005
Sleep hygiene practices in a population-based sample of insomniacsCatherine D Jefferson, Christopher L Drake, Holly M Scofield, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 15, 2007
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depressionAndrew Krystal, Maurizio Fava, Robert Rubens, et al.
Journal of Sleep Research|August 4, 2009
Cortical locations of maximal spindle activity: magnetoencephalography (MEG) studyValentina Gumenyuk, Thomas Roth, John E Moran, et al.
Journal of Clinical Pharmacology|August 14, 2013
Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tabletsDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
Pageof 40